المؤلفون: Yuxiang Ma, Ming Zhao, Yan Huang, Xiuyu Cai, Wenqi Jiang, Yixin Zhou, Hongyun Zhao, Chen Chen, Xiaoshi Zhang, Wenfeng Fang, Zuan Lin, Shaodong Hong, Li Zhang, Xuanye Zhang, Rui-Hua Xu, Yunpeng Yang, Bei Zhang

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, HBsAg, medicine.medical_treatment, Programmed Cell Death 1 Receptor, medicine.disease_cause, Gastroenterology, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Neoplasms, PD-1, Immunology and Allergy, Cancer, biology, Checkpoint, virus diseases, Middle Aged, Reactivation, Hepatitis B, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, virology, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, Safety, Antibody, liver disease, Research Article, Adult, PD-L1, medicine.medical_specialty, Hepatitis B virus, Immunology, Antiviral Agents, lcsh:RC254-282, Young Adult, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Retrospective Studies, Pharmacology, Hepatitis, Chemotherapy, Hepatitis B Surface Antigens, business.industry, medicine.disease, digestive system diseases, 030104 developmental biology, Alanine transaminase, Commentary, biology.protein, Virus Activation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea49583d5b5c254a92def2d9371d965Test
http://link.springer.com/article/10.1186/s40425-019-0808-5Test

المؤلفون: Stefani Spranger, Lauren L. Ritterhouse, Jonathan A. Trujillo, Jason J. Luke, Karen Matijevich, Jeremy P. Segal, Thomas F. Gajewski, Yuanyuan Zha

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 0302 clinical medicine, Antineoplastic Agents, Immunological, PTEN-loss, Immunology and Allergy, β-Catenin activation, CTLA-4 Antigen, Melanoma, beta Catenin, Peptide vaccine, biology, High-Throughput Nucleotide Sequencing, Immune exclusion, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Interleukin-12, 3. Good health, medicine.anatomical_structure, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Immunotherapy, Antibody, Research Article, Signal Transduction, Adult, Metastatic melanoma, T cell, Immunology, Secondary resistance, Cancer Vaccines, lcsh:RC254-282, 03 medical and health sciences, Young Adult, medicine, PTEN, Humans, Pharmacology, business.industry, PTEN Phosphohydrolase, Ipilimumab, Blockade, 030104 developmental biology, Drug Resistance, Neoplasm, Catenin, biology.protein, Cancer research, Next-generation sequencing, business, Transcriptome, Immune checkpoint blockade

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b7cfeb16493056edddd6f47f459901Test
http://link.springer.com/article/10.1186/s40425-019-0780-0Test

المؤلفون: Philip Beale, Yoland Antill, Sonia Yip, Amanda B. Spurdle, Kristy P. Robledo, Catherine Shannon, Elizabeth H Barnes, Deborah Smith, Tarek Meniawy, Peey-Sei Kok, Michelle M. Cummins, Michael Friedlander, Jermaine Coward, Sally Baron-Hay, Linda Mileshkin, Martin R. Stockler, John Andrews, Geraldine Goss, Janine M. Lombard, Yeh Chen Lee

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Durvalumab, medicine.medical_treatment, Immunology, Phases of clinical research, DNA Mismatch Repair, programmed cell death 1 receptor, Drug Administration Schedule, Antineoplastic Agents, Immunological, Internal medicine, Clinical endpoint, Immunology and Allergy, Medicine, Humans, Adverse effect, RC254-282, Aged, Pharmacology, Clinical/Translational Cancer Immunotherapy, Chemotherapy, clinical trials, business.industry, Endometrial cancer, phase II as topic, Antibodies, Monoclonal, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Survival Analysis, Endometrial Neoplasms, Clinical trial, Treatment Outcome, Cohort, Molecular Medicine, Female, immunotherapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a56b01ba8ce00e7efa33f5ce36561b0Test
https://jitc.bmj.com/content/9/6/e002255.fullTest

المؤلفون: Peixin Chen, Chunyan Wu, Minlin Jiang, Yi Xu, Liping Zhang, Jun Zhu, Chenglong Sun, Yayi He, Jia Yu, Caicun Zhou, Shengyu Wu, Hao Wang, Qiyu Fang, Hui Sun, Wencheng Zhao, Zixuan Zheng

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: lymphocytes, Male, Oncology, Cancer Research, Lung Neoplasms, Time Factors, Machine Learning, Risk Factors, Immunotherapy Biomarkers, Tumor Microenvironment, Immunology and Allergy, RC254-282, Aged, 80 and over, Framingham Risk Score, biology, FOXP3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Forkhead Transcription Factors, Middle Aged, Immunohistochemistry, Treatment Outcome, Molecular Medicine, Female, Adult, tumor, medicine.medical_specialty, CD3, Immunology, chemical and pharmacologic phenomena, Risk Assessment, programmed cell death 1 receptor, Decision Support Techniques, Immune system, Predictive Value of Tests, Internal medicine, Biomarkers, Tumor, medicine, Humans, Lung cancer, Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, Tumor microenvironment, business.industry, biomarkers, tumor-infiltrating, medicine.disease, Small Cell Lung Carcinoma, Nomograms, biology.protein, Neoplasm Recurrence, Local, business, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a0c7a5fab406d27ac6fcb367c98307Test
https://jitc.bmj.com/content/9/5/e002339.fullTest

المؤلفون: Chunyan Lan, Zhimin Liu, Dongqin Zhu, Fan Yang, Minjun He, Hongyu Peng, Chongjie Tong, Xiao-Long Zhang, Xin Huang, Jiani C. Yin, Junli Zhang, Yang Shao

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Time Factors, Pyridines, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Phases of clinical research, Uterine Cervical Neoplasms, chemistry.chemical_compound, 0302 clinical medicine, Risk Factors, Immunotherapy Biomarkers, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Apatinib, Immune Checkpoint Inhibitors, RC254-282, Cervical cancer, biology, medicine.diagnostic_test, High-Throughput Nucleotide Sequencing, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, drug therapy, Gene Expression Regulation, Neoplastic, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Female, immunotherapy, Signal Transduction, Adult, medicine.medical_specialty, Combination therapy, Immunology, Antibodies, Monoclonal, Humanized, Risk Assessment, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, Biopsy, medicine, PTEN, Humans, Protein Kinase Inhibitors, PI3K/AKT/mTOR pathway, Aged, combination, Pharmacology, business.industry, Gene Expression Profiling, Immunotherapy, medicine.disease, 030104 developmental biology, chemistry, genetic markers, biology.protein, business, Transcriptome

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04b4bdd5597fc08e7efbeb45dcf1695Test
https://jitc.bmj.com/content/9/5/e002223.fullTest

المؤلفون: Soudabeh Rad Pour, Xavier Martinez Demorentin, Yago Pico de Coaña, David Gomez-Cabrero, Maria Wolodarski, Johan Hansson, Manjula Thimma, Rolf Kiessling, Jeroen Melief, Jesper Tegnér

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, active, Monocytes, 0302 clinical medicine, Immunology and Allergy, RNA-Seq, Immune Checkpoint Inhibitors, Melanoma, RC254-282, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, medicine.diagnostic_test, CD4-CD8 ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Flow Cytometry, Nivolumab, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, Single-Cell Analysis, Adult, medicine.medical_specialty, Immunology, therapies, investigational, Peripheral blood mononuclear cell, Flow cytometry, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, gene expression profiling, medicine, Calgranulin B, Humans, Aged, Sweden, Pharmacology, business.industry, Monocyte, Immunotherapy, medicine.disease, Blockade, 030104 developmental biology, business, Checkpoint Blockade Immunotherapy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dce267ed6b6145ca7733d8384ece8faTest
https://jitc.bmj.com/content/9/5/e002171.fullTest

المؤلفون: Angen Liu, Robert L. Ferris, Dan P. Zandberg, Ashley V. Menk, Maria A. Velez, Greg M. Delgoffe, Kristin DePeaux, Daniel P. Normolle

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)

مصطلحات موضوعية: 0301 basic medicine, lymphocytes, Male, Cancer Research, medicine.medical_treatment, T-Lymphocytes, Programmed Cell Death 1 Receptor, 0302 clinical medicine, Antineoplastic Agents, Immunological, Tumor Microenvironment, Immunology and Allergy, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunosuppression, Middle Aged, Progression-Free Survival, Tumor Burden, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, medicine.symptom, metabolic networks and pathways, Oxidation-Reduction, Signal Transduction, Adult, Immunology, 03 medical and health sciences, head and neck neoplasms, Lymphocytes, Tumor-Infiltrating, Cell Line, Tumor, medicine, Pimonidazole, Animals, Humans, Progression-free survival, Aged, Retrospective Studies, Pharmacology, Tumor microenvironment, Tumor hypoxia, business.industry, Squamous Cell Carcinoma of Head and Neck, Immunotherapy, Hypoxia (medical), tumor-infiltrating, Xenograft Model Antitumor Assays, Mice, Inbred C57BL, 030104 developmental biology, Drug Resistance, Neoplasm, Cancer research, Tumor Hypoxia, business, Energy Metabolism, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a738a335f0dbb51e76431215797d38Test
http://europepmc.org/articles/PMC8126285Test

المؤلفون: Jeffrey R. Infante, Patrick Schöffski, Michael S. Gordon, Alain Ravaud, Manish Agrawal, John Allan Ellerton, Juliane Manitz, Manish R. Patel, Mary Ruisi, Andrea B. Apolo, Matthew H. Taylor, Luc Dirix, Ding Wang, Keun Wook Lee, Raid Aljumaily, Gregory Pennock, Theodore Gourdin, J.L. Gulley

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Immunology, Antibodies, Monoclonal, Humanized, Gastroenterology, B7-H1 Antigen, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Programmed cell death 1, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, Humans, Until Disease Progression, Solid tumor, RC254-282, Urothelial carcinoma, Aged, Platinum, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, Second-line therapy, Carcinoma, Transitional Cell, biology, clinical trials as topic, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Toxicity, biology.protein, Molecular Medicine, Female, business, urinary bladder neoplasms, medicine.drug

وصف الملف: Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b9fa96546aac04d870e76ec58182cTest
https://jitc.bmj.com/content/8/2/e001246.fullTest

المؤلفون: Yaping Wu, Brendan D. Curti, Zhaoyu Sun, William L. Redmond, Brady Bernard, Christopher B. Fountain, Peter G. Traber, Takashi Shimada, Yoshinobu Koguchi, Rom Leidner, Eliezer Zomer, Elizabeth Sturgill, George Morris, Venkatesh Rajamanickam, Noriko Iwamoto, Annah S Rolig, Ian Hilgart-Martiszus, J. Rex Horton, Shu Ching Chang, Harold Shlevin

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Immune Checkpoint Inhibitors, T-lymphocytes, RC254-282, Clinical/Translational Cancer Immunotherapy, clinical trials as topic, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Blood Proteins, Middle Aged, Treatment Outcome, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, immunohistochemistry, Molecular Medicine, Pectins, Female, Multiple Myeloma, Adult, medicine.medical_specialty, Galectins, Immunology, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Memory T Cells, Immune system, Internal medicine, medicine, Humans, Aged, Pharmacology, Autoimmune disease, business.industry, Squamous Cell Carcinoma of Head and Neck, Myeloid-Derived Suppressor Cells, Immunotherapy, medicine.disease, Head and neck squamous-cell carcinoma, Blockade, 030104 developmental biology, Myeloid-derived Suppressor Cell, business, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a1c844347afeb00988b18adab8210aeTest
https://jitc.bmj.com/content/9/4/e002371.fullTest

المؤلفون: Stefan Traint, Sebastian Bauer, Thomas Brodowicz, Gerwin Heller, Katharina Feldmann, Julia Furtner, Gabriele Amann, Rainer Hamacher, Teresa Hatziioannou, Iris M. Noebauer-Huhmann, Leonhard Müllauer, Wolfgang Lamm, Angelika M. Starzer, Erwin Tomasich, Hans-Ulrich Schildhaus, Anna S. Berghoff, Matthias Preusser

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Epigenomics, Male, 0301 basic medicine, Cancer Research, Time Factors, sarcoma, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, biostatistics, Soft Tissue Neoplasms, Epigenome, 0302 clinical medicine, Germany, Immunotherapy Biomarkers, Tumor Microenvironment, Immunology and Allergy, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, Osteosarcoma, Predictive marker, FOXP3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Methylation, Middle Aged, Progression-Free Survival, Oncology, CpG site, Austria, 030220 oncology & carcinogenesis, DNA methylation, Molecular Medicine, Female, immunotherapy, Sarcoma, Signal Transduction, Adult, tumor, Immunology, Bone Neoplasms, Young Adult, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, medicine, Humans, Aged, Retrospective Studies, Pharmacology, business.industry, biomarkers, Immunotherapy, DNA Methylation, medicine.disease, Immune checkpoint, 030104 developmental biology, Cancer research, CpG Islands, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757e63d071fac70057305b1163d6f22aTest
https://jitc.bmj.com/content/9/3/e001458.fullTest